UBS O'Connor’s Agios Pharmaceuticals AGIO Stock Holding History

UBS O'Connor’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-56,810	Closed	-$1.89M	–	277
2025 Q2	$1.89M	Sell	56,810 -1,912	-3%	-$58K	0.05%	166
2025 Q1	$1.72M	Buy	58,722 +15,392	+36%	+$511K	0.04%	138
2024 Q4	$1.42M	Buy	43,330 +22,243	+105%	+$1.04M	0.04%	199
2024 Q3	$937K	Sell	21,087 -8,926	-30%	-$405K	0.02%	286
2024 Q2	$1.29M	Sell	30,013 -49,893	-62%	-$1.8M	0.04%	261
2024 Q1	$2.34M	Sell	79,906 -46,913	-37%	-$1.26M	0.07%	152
2023 Q4	$2.82M	Buy	126,819 +21,598	+21%	+$484K	0.09%	126
2023 Q3	$2.6M	Buy	105,221 +39,000	+59%	+$1.03M	0.05%	193
2023 Q2	$1.88M	Buy	66,221 +13,721	+26%	+$341K	0.04%	308
2023 Q1	$1.21M	Buy	+52,500	New	+$1.39M	0.03%	387
2016 Q2	–	Sell	-8,076	Closed	-$328K	–	401
2016 Q1	$328K	Buy	+8,076	New	+$345K	0.01%	379
2013 Q4	–	Sell	-20,000	Closed	-$559K	–	404
2013 Q3	$559K	Buy	+20,000	New	+$552K	0.01%	322

Other funds holding AGIO

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return